Generation and characterization of antibodies specific for caspase-cleaved neo-epitopes: A novel approach

Cell Death and Disease

Volumn 2, Issue 9, 2011, Pages

  Ai, X ^a   Butts, B ^a   Vora, K ^a   Li, W ^a   Tache Talmadge, C ^a   Fridman, A ^a   Mehmet, H ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Apoptosis; Biomarker; Neo epitope antibodies

Indexed keywords

ANTIGEN; CASPASE; EPITOPE; MONOCLONAL ANTIBODY; PROTEINASE;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CELL CULTURE; CELL LYSATE; CONTROLLED STUDY; ENZYME ACTIVE SITE; HUMAN; HUMAN CELL; HYPOTHESIS; IMMUNIZATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; SUPERNATANT;

ANIMALS; ANTIBODIES; APOPTOSIS; CASPASES; CELL LINE, TUMOR; EPITOPES; FLUOROURACIL; HUMANS; IMMUNOPRECIPITATION; OLIGOPEPTIDES; RABBITS;

ORYCTOLAGUS CUNICULUS;

EID: 80053387466     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2011.91     Document Type: Article

References (21)

1. Fulda S, Debatin KM. Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene 2006; 25: 4798-4811. (Pubitemid 44187627)
2. Fulda S. Exploiting apoptosis pathways for the treatment of pediatric cancers. Pediatr Blood Cancer 2009; 53: 533-536.
3. Sarker D, Workman P. Pharmacodynamic biomarkers for molecular cancer therapeutics. Adv Cancer Res 2007; 96: 213-268.
4. Amur S, Frueh FW, Lesko LJ, Huang SM. Integration and use of biomarkers in drug development, regulation and clinical practice: a US regulatory perspective. Biomark Med 2008; 2: 305-311.
5. Ward T, Cummings J, Dean E, Greystoke A, Hou JM, Backen A et al. Biomarkers of apoptosis. Br J Cancer 2008; 99: 841-846.
6. Brandt D, Volkmann X, Anstatt M, Langer F, Manns MP, Schulze-Osthoff K et al. Serum biomarkers of cell death for monitoring therapy response of gastrointestinal carcinomas. Eur J Cancer 2010; 46: 1464-1473.
7. Teraoka H, Yumoto Y, Watanabe F, Tsukada K, Suwa A, Enari M et al. CPP32/Yama/ apopain cleaves the catalytic component of DNA-dependent protein kinase in the holoenzyme. FEBS Lett 1996; 393: 1-6. (Pubitemid 26298217)
8. Valencia CA, Bailey C, Liu R. Novel zebrafish caspase-3 substrates. Biochem Biophys Res Commun 2007; 361: 311-316. (Pubitemid 47187260)
9. Linder S, Alaiya A. Serum efficacy biomarkers for oncology. Biomark Med 2009; 3: 47-54.
10. Dix MM, Simon GM, Cravatt BF. Global mapping of the topography and magnitude of proteolytic events in apoptosis. Cell 2008; 134: 679-691.
11. Ravi R, Bedi A, Fuchs EJ, Bedi A. CD95 (Fas)-induced caspase-mediated proteolysis of NF-kappa B. Cancer Res 1998; 58: 882-886. (Pubitemid 28182451)
12. Siman R, Bozyczko-Coyne D, Meyer SL, Bhat RV. Immunolocalization of caspase proteolysis in situ: evidence for widespread caspase-mediated apoptosis of neurons and glia in the postnatal rat brain. Neuroscience 1999; 92: 1425-1442. (Pubitemid 29292578)
13. Terwel D, Van de Berg W. c-Jun/AP-1 (N) directed antibodies cross-react with 'apoptosisspecific protein' which marks an autophagic process during neuronal apoptosis. Neuroscience 2000; 96: 445-446. (Pubitemid 30100426)
14. Ribera J, Ayala V, Esquerda JE. c-Jun-like immunoreactivity in apoptosis is the result of a crossreaction with neoantigenic sites exposed by caspase-3-mediated proteolysis. J Histochem Cytochem 2002; 50: 961-972. (Pubitemid 34774607)
15. Casas C, Ribera J, Esquerda JE. Antibodies against c-Jun N-terminal peptide cross-react with neo-epitopes emerging after caspase-mediated proteolysis during apoptosis. J Neurochem 2001; 77: 904-915. (Pubitemid 32466787)
16. Mahrus S, Trinidad JC, Barkan DT, Sali A, Burlingame AL, Wells JA. Global sequencing of proteolytic cleavage sites in apoptosis by specific labeling of protein N termini. Cell 2008; 134: 866-876.
17. Luthi AU, Martin SJ. The CASBAH: a searchable database of caspase substrates. Cell Death Differ 2007; 14: 641-650. (Pubitemid 46444502)
18. Nahas DD, Palladino JS, Joyce JG, Hepler RW. Amino acid analysis of peptide loading ratios in conjugate vaccines: a comparison of direct electrochemical detection and 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate pre-column derivatization methods. Bioconjug Chem 2008; 19: 322-326. (Pubitemid 351213865)
19. Donnelly JJ, Deck RR, Liu MA. Immunogenicity of a Haemophilus influenzae polysaccharide-Neisseria meningitidis outer membrane protein complex conjugate vaccine. J Immunol 1990; 145: 3071-3079. (Pubitemid 20382582)
20. Bianchi E, Liang XP, Ingallinella P, Finotto M, Chastain MA, Fan J et al. Universal influenza B vaccine based on the maturational cleavage site of the hemagglutinin precursor. J Virol 2005; 79: 7380-7388. (Pubitemid 40756774)
21. Fan JA, Liang XP, Horton MS, Perry HC, Citron MP, Heidecker GJ et al. Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys. Vaccine 2004; 22: 2993-3003. (Pubitemid 39037199)